Nanobodies News and Research

RSS
Immune particles from llama blood could offer protection against several COVID-19 variants

Immune particles from llama blood could offer protection against several COVID-19 variants

Super-immunity in a camelid extensively immunized with the SARS-CoV-2 receptor-binding domain

Super-immunity in a camelid extensively immunized with the SARS-CoV-2 receptor-binding domain

Tiny shark-derived antibodies broadly neutralize most SARS-CoV-2 variants

Tiny shark-derived antibodies broadly neutralize most SARS-CoV-2 variants

Nanobodies from llamas could be used to deliver targeted medicines to human muscle cells

Nanobodies from llamas could be used to deliver targeted medicines to human muscle cells

Nanobody effectively neutralizes pseudotyped ancestral SARS-CoV-2 and Omicron spike proteins

Nanobody effectively neutralizes pseudotyped ancestral SARS-CoV-2 and Omicron spike proteins

Using customized 'mini-antibodies' to mitigate chronic inflammation

Using customized 'mini-antibodies' to mitigate chronic inflammation

Study shows circular RNA vaccine provides robust protection against SARS-CoV-2 in mice and rhesus macaques

Study shows circular RNA vaccine provides robust protection against SARS-CoV-2 in mice and rhesus macaques

Developing and manufacturing custom recombinant antibodies for R&D

Developing and manufacturing custom recombinant antibodies for R&D

ProteoGenix launches new XtenCHOTM Transient CHO Expression System to improve biologics development

ProteoGenix launches new XtenCHOTM Transient CHO Expression System to improve biologics development

A new strategy for identifying potent miniature antibodies against emerging SARS-CoV-2 variants

A new strategy for identifying potent miniature antibodies against emerging SARS-CoV-2 variants

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

SARS-CoV-2 nanobody that binds to the receptor-binding domain could prevent  COVID-19 in animals

SARS-CoV-2 nanobody that binds to the receptor-binding domain could prevent COVID-19 in animals

Covalent protein nanobodies for neutralizing SARS-CoV-2 and its variants

Covalent protein nanobodies for neutralizing SARS-CoV-2 and its variants

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

Identification of a rapid test for SARS-CoV-2 neutralization via antibodies and nanobodies

Identification of a rapid test for SARS-CoV-2 neutralization via antibodies and nanobodies

Molecular characteristics of SARS-CoV-2 variants enabling antibody escape

Molecular characteristics of SARS-CoV-2 variants enabling antibody escape

Inhalable antibody fragments offer broad protection from SARS-CoV-2 variants

Inhalable antibody fragments offer broad protection from SARS-CoV-2 variants

Alpaca-derived antibody fragment disrupts interaction between SARS-CoV-2 spike protein and human ACE2

Alpaca-derived antibody fragment disrupts interaction between SARS-CoV-2 spike protein and human ACE2

Study finds pan-sarbecovirus nanobodies can enhance development of super-immunity

Study finds pan-sarbecovirus nanobodies can enhance development of super-immunity

Scientists identify a panel of nanobodies with good neutralizing efficacy against SARS-CoV-2 variants of concern

Scientists identify a panel of nanobodies with good neutralizing efficacy against SARS-CoV-2 variants of concern